Related Experiment Videos
Interactions of platelets with Synthocytes, a novel platelet substitute
A R Davies1, H M Judge, J A May
1Centre for Vascular Research, University of Nottingham, Cardiovascular Medicine, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Platelets
|August 22, 2002
Summary
Synthocytes, a novel platelet substitute, interact with platelets by binding fibrinogen to GPIIb/IIIa receptors. This interaction promotes platelet activation and aggregation, potentially aiding hemostasis in thrombocytopenia.
Area of Science:
- Biomaterials Science
- Hematology
- Nanotechnology
Background:
- Thrombocytopenia poses significant bleeding risks.
- Platelet transfusions are a common treatment but face limitations.
- Synthocytes are engineered microcapsules designed as a platelet substitute.
Purpose of the Study:
- To investigate the in vitro interaction between Synthocytes and platelets.
- To elucidate the mechanisms by which Synthocytes may contribute to hemostasis.
- To assess the role of fibrinogen and platelet receptors in Synthocyte-platelet interactions.
Main Methods:
- Platelet aggregation assays.
- [(14)C]5HT release measurements.
- Flow cytometry with P-selectin and annexin V staining.
- Experiments with control microcapsules and receptor antagonists (ADP, GPIIb/IIIa).
Main Results:
- Synthocytes induced platelet aggregation and serotonin release.
- Flow cytometry confirmed platelet-Synthocyte co-aggregate formation with activated platelets.
- Synthocytes enhanced platelet responsiveness to ADP and increased pro-coagulant activity.
- Fibrinogen on Synthocytes was crucial for these interactions.
Conclusions:
- Fibrinogen on Synthocytes interacts with platelet GPIIb/IIIa receptors, leading to activation and aggregation.
- ADP plays a synergistic role in Synthocyte-mediated platelet activation.
- Synthocyte-platelet interactions may contribute to primary hemostasis in thrombocytopenic patients.